Paragon 28, Inc. (NYSE:FNA) Major Shareholder Sells $732,871.28 in Stock

Paragon 28, Inc. (NYSE:FNA) major shareholder Mvm Partners, Llc sold 72,133 shares of the firm’s stock in a transaction dated Friday, November 22nd. The shares were sold at an average price of $10.16, for a total value of $732,871.28. Following the transaction, the insider now owns 10,559,065 shares of the company’s stock, valued at approximately $107,280,100.40. The trade was a 0.68 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Mvm Partners, Llc also recently made the following trade(s):

• On Monday, November 25th, Mvm Partners, Llc sold 10,835 shares of Paragon 28 stock. The shares were sold at an average price of $10.09, for a total value of $109,325.15.
• On Wednesday, November 20th, Mvm Partners, Llc sold 147,581 shares of Paragon 28 stock. The shares were sold at an average price of $10.28, for a total value of $1,517,132.68.

Paragon 28 Trading Up 1.2 %

NYSE FNA traded up $0.12 during trading on Tuesday, hitting $9.98. The stock had a trading volume of 651,589 shares, compared to its average volume of 615,094. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50. The stock has a market capitalization of $835.53 million, a price-to-earnings ratio of -13.34 and a beta of 1.01. Paragon 28, Inc. has a one year low of $4.65 and a one year high of $14.79. The stock has a 50 day simple moving average of $6.77 and a 200 day simple moving average of $7.22.

Paragon 28 (NYSE:FNA) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.01. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. The firm had revenue of $62.30 million during the quarter, compared to the consensus estimate of $60.58 million. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. The company’s revenue was up 18.0% on a year-over-year basis. Sell-side analysts predict that Paragon 28, Inc. will post -0.66 earnings per share for the current year.

Institutional Trading of Paragon 28

Institutional investors and hedge funds have recently modified their holdings of the stock. Nisa Investment Advisors LLC increased its holdings in Paragon 28 by 46,660.0% during the second quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company’s stock valued at $32,000 after buying an additional 4,666 shares during the period. Levin Capital Strategies L.P. purchased a new position in Paragon 28 in the second quarter worth $68,000. Intech Investment Management LLC purchased a new position in Paragon 28 in the third quarter worth $70,000. Ballentine Partners LLC purchased a new position in Paragon 28 in the third quarter worth $91,000. Finally, Creative Planning purchased a new position in Paragon 28 in the third quarter worth $91,000. Institutional investors own 63.57% of the company’s stock.

Analysts Set New Price Targets

FNA has been the subject of a number of analyst reports. Piper Sandler reaffirmed an “overweight” rating and issued a $12.00 price target (down previously from $15.00) on shares of Paragon 28 in a report on Friday, August 9th. Canaccord Genuity Group lowered their price target on shares of Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Finally, Needham & Company LLC increased their price target on shares of Paragon 28 from $11.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $15.60.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.